Gamma/delta T cells provide innate immunity against renal cell carcinoma

Cancer Immunology, Immunotherapy

Volumn 50, Issue 3, 2001, Pages 115-124

  Kobayashi, Hirohito ^a   Tanaka, Yoshimasa ^a   Yagi, Junji ^a   Toma, Hiroshi ^a   Uchiyama, Takehiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Flow cytometry; Immunotherapy; Renal cell carcinoma; T cell; V 2 and V 2 junction sequences

Indexed keywords

ADULT; AGED; ANTIGEN RECOGNITION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER STAGING; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNITY;

ADULT; AGED; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CLONING, MOLECULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; TIME FACTORS;

EID: 0035009499     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620100173     Document Type: Article

References (44)

1. 1. deRise W, Allhoff E, Kirchner H, Stief CG, Atzpodien J, Maschek H, Jonas U (1991) Complete spontaneous regression in metastatic renal cell carcinoma - an update and review. World J Urol 9: 1841
2. 2. Dekernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148
3. 3. Rosenberg SA, Yang JC, Topalian SL, Schwartzentruber DJ, Weber JS, Parkinson DR, Seipp CA, Einhorn JH, White DE (1994) Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 271: 907
4. 4. Negrier S, Escudier B, Lasset C, Douillard JY, Savary J, Chevreau C, Ravaud A, Mercatello A, Peny J, Mousseau M, Philip T, Tursz T (1988) Recombinant human interleukin-2, recombinant human interferon alfa-2a, or both in metastatic renal-cell carcinoma. N Engl J Med 338: 1272
5. 5. Aulitzky W, Gastl G, Aulitzky WE, Herold M, Kemmler J, Mull B, Frick J, Huber C (1989) Successful treatment of metastatic renal cell carcinoma with a biologically active dose of recombinant interferon-gamma. J Clin Oncl 7: 1875
6. 6. Rosenberg SA, Lotze MT, Muul LM, Leitman S, Chang AE, Ettinghausen SE, Matory YL, Skibber JM, Shiloni E, Vetto JT, Seioo CA, Simpson C, Reichert CM (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med 313: 1485
7. 7. Rosenberg SA, Lotze MT, Muul LM, Chang AE, Avis FP, Leitman S, Linehan WM, Robertson CN, Lee RE, Rubin JT, Seipp CA, Simpson CG, White DE (1987) A progress report on the treatment of advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 316: 889
8. 8. Rosenberg SA, Spiess P, Lafreniere R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318
9. 9. Hayakawa K, Salmeron MA, Parkinson DR, Morkowitz AB, von Eschenbach AC, Legha SS, Balch CM, Ross MI, Augustus LB, Ito K (1991) Study of tumor-infiltrating lymphocytes for adoptive therapy of renal cell carcinoma (RCC) and metastatic melanoma: sequential proliferation of cytotoxic natural killer and noncytotoxic T cell in RCC. J Immunother 10: 313
10. 10. Morales A, Wilson JL, Pater JL, Loeb M (1981) Cytoreductive surgery and systemic Bacillus Calmette-Guerin therapy in metastatic renal cancer: a phase II trial. J Urol 127: 230
11. 11.Porcelli S, Brenner MB, Band H (1991) Biology of human γδ-T cell receptor. Immunol Rev 120: 137
12. 12. Ueta C, Tsuyuguchi I, Kawasumi H, Takashima T, Toba H, Kishimoto S (1994) Increase of γ/δ T cells in hospital workers who are in close contact with tuberculosis patients. Infect Immun 62: 5434
13. 13. Kara T, Mizuno Y, Takaki K, Takada H, Akeda H, Aoki T, Nagata M, Ueda K, Matsudaki G, Yoshikai Y, Nomoto K (1992) Predominant activation and expansion of Vγ9-bearing γδ T cells in vivo as well as in vitro in Salmonella infection. J Clin Invest 90: 204
14. 14. Sumida T, Maeda T, Takahashi H, Yoshida S, Yonaha F, Sakamoto A, Tomioka H, Koike T, Yoshida S (1992) Predominant expansion of Vγ9/Vδ2 cells in a tularemia patient. Infect Immun 60: 2554
15. 15. Modlin RL, Pirmez C, Hofman FM, Torigian V, Uyemura K, Rea TH, Bloom BR, Brenner MB (1989) Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions. Nature 339: 544
16. 16. Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR (1995) Natural and synthetic nonpeptide antigens recognized by human γδ T cells. Nature 375: 155
17. 17. Constant P, Davodeau F, Peyrat MA, Poquet Y, Puzo G, Bonneville M, Fournié JJ (1994) Stimulation of human γδ T cells by nonpeptidic mycobacterial ligands. Science 264: 267
18. 18. Follows GA, Munk ME, Gatrill AJ, Conradt P, Kaufmann SHE (1992) Gamma interferon and interleukin 2, but not interleukin 4, are detectable in γ/δ T-cell cultures after activation with bacteria. Infect Immun 60: 1229
19. + α/β T cell and γ/δ T cell responses to Mycobacterium tuberculosis. Similarities and differences in Ag recognition, cytotoxic effector function, and cytokine production. J Immunol 154: 1786
20. 20. Zocchi MR, Ferrarini M, Nigone M, Casorati G (1994) T-cell receptor Vδ gene usage by tumor reactive γδ T lymphocytes infiltrating human lung cancer. Immunology 81: 234
21. 21. Bunsussan A, Lagabrielle JF, Degos L (1989) TCR γδ bearing lymphocyte clones with lymphokine-activated killer activity against autologous leukemic cells. Blood 73: 2077
22. 22. Takahashi N, Imanishi K, Nishida H, Uchiyama T (1995) Evidence for immunologic immaturity of cord blood T cells: cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 155: 5213
23. 23. Eskelinen M, Lipponen P, Aitto-Oja L, Hall O, Syrjanen K (1993) The value of histoquantitative measurements in prognostic assessment of renal adenocarcinoma. Int J Cancer 55: 547
24. 24. Tamura N, Holroyd KJ, Banks T, Kirby M, Okayama H, Crystal RG (1990) Diversity in junctional sequences associated with the common human Vγ9 and Vδ2 gene segments in normal blood and lung compared with the limited diversity in a granulomatous disease. J Exp Med 172: 169
25. 25. Usubutun A, Ayhan A, Uygur MC, Ozen H, Toklu C, Ruacan S (1998) Prognostic factors in renal cell carcinoma. J Exp Clin Cancer Res 17: 77
26. 26. Riethmüller G, Johnson JP (1992) Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers. Curr Opin Immunol 4: 641
27. 27. Mitropoulos D, Kool S, R. Villanueva J, Platsoucas CD (1994) Characterization of fresh (uncultured) tumor-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin Exp Immunol 97: 321
28. 28. Nanno M, Seki H, Mathioudakis G, Suzuki R, Itoh K, Ioannides CG, Suzuki S, Chen PF, Plastsoucas CD (1992) γ/δ T cells antigen receptor expressed on tumor-infiltrating lymphocytes from patients with solid tumors. Eur J Immunol 22: 679
29. 29. Schild H, Mavaddat N, Litzenberger C, Ehrich EW, Davis MM, Bluestone JA, Matis L, Draper RK, Chien YH (1994) The nature of major histocompatibility complex recognition by γδ T cell. Cell 76: 29
30. 30. Holoshitz J, Vila LM, Keroack BJ, McKinley DR, Bayne NK (1992) Dual recognition by cloned human γδ T cells. J Clin Invest 89: 308
31. 31. Poccia F, Cipriani B, Vendetti S, Colizzi V, Poquet Y, Battistini L, Lopez-Botet M, Fournié J, Gougeon M (1997) CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral response of polyclonal phosphoantigen-reactive Vγ9Vδ2 T lymphocytes. J Immunol 159: 6009
32. 32. Boullier S, Poquet Y, Halary F, Bonneville M, Fournie J, Gougeon M (1998) Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2 A class I receptor on CD94-peripheral Vγ9Vδ2 T cells but not on CD94-thymic or mature γδ T cell clones. Eur J Immunol 28: 3399
33. 33. Tomita Y, Nishiyama T, Fujiwara M, Sato S (1990) Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer. Br J Cancer 62: 354
34. 34. Cordon-Cardo C, Fuks Z, Drobnjak M, Moreno C, Eisenbach L, Feldman M (1991) Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res 51: 6372
35. 35. Choudhary A, Davodeau F, Moreau A, Peyrat NA, Bonneville M, Jotereau F (1995) Selective lysis of autologous tumor cells by recurrent γδ tumor-infiltrating lymphocytes from renal carcinoma. J Immunol 154: 3932
36. 36. Kowalczyk D, Skorupski W, Kwais Z, Nowak J (1996) Activated gamma/delta T lymphocytes infiltrating renal cell carcinoma. Immunol Lett 53: 15
37. 37. Kobayashi E, Yamauchi H (1997) Interleukin-6 and a delay of neutrophil apoptosis after major surgery. Arch Surg 132: 209
38. 38. Oka M, Hirazawa K, Yamamoto K, Iizuka N, Hazama S, Suzuki T (1996) Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress. Ann Surg 223: 434
39. 39. Ebato M, Nitta T, Yagita H, Sato K, Okumura K (1994) Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma. Eur J Immunol 24: 2987
40. 40. Nitta T, Sato K, Okumura K, Steinman L (1991) An analysis of T-cell-receptor variable-region genes in tumor-infiltrating lymphocytes within malignant tumors. Int J Cancer 49: 545
41. 41. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335: 865
42. 42. Montie JE, Bukowski RM, James RE, Straffon RA, Stewart BH (1982) A critical review of immunotherapy of disseminated renal adenocarcinoma. J Surg Oncol 21: 5
43. 43. Belldegrum A, Figlin R, Haas G, deKernion J (1991) Immunotherapy for metastatic renal-cell carcinoma. World J Urol 9: 157
44. 44. Ebina T, Fujimiya Y, Yamaguchi T, Ogama N, Sasaki H, Isono N, Suzuki Y, Katakura R, Tanaka K, Nagata K, Takano S, Tamura K, Uno K, Kishida T (1998) The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients. Biotherapy 11: 241